Results 221 to 230 of about 236,648 (327)
In silico modeling of patient-specific blood rheology in type 2 diabetes mellitus. [PDF]
Han K +7 more
europepmc +1 more source
Cinnamic‐hydroxamic‐acid derivatives (CHADs) are identified as novel inhibitors of the bacterial nucleoid‐associated protein HU, exhibiting potent antibacterial, anti‐biofilm (both inhibition and eradication), and DNA relaxation (anti‐supercoiling) activities. Moreover, CHADs demonstrate strong synergistic effects with multiple antibiotics.
Huan Chen +22 more
wiley +1 more source
In Silico Modeling of Stress Distribution in the Diseased Ankle Joint. [PDF]
Lorkowski J, Mrzyglod MW, Pokorski M.
europepmc +1 more source
BioE is a new diiron oxygenase that catalyzes the conversion of long‐chain acyl groups into pimeloyl thioester, initiating biotin synthesis. The overexpression of EmBioE disrupts lipid metabolic homeostasis, requiring repressor BioL to maintain a balance between long‐chain fatty acids and biotin synthesis.
Meng Zhang +9 more
wiley +1 more source
Engineering a computable epiblast for in silico modeling of developmental toxicity. [PDF]
Barham K +3 more
europepmc +1 more source
Bacterial Tyrosinase Inhibition, Hemolytic and Thrombolytic Screening, and In Silico Modeling of Rationally Designed Tosyl Piperazine-Engrafted Dithiocarbamate Derivatives. [PDF]
Zahoor AF +9 more
europepmc +1 more source
A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness
Disorders of consciousness after severe brain injury are marked by reduced complexity of brain activity and limited treatment options. Using personalized whole‐brain models, this study shows that simulated lysergic acid diethylamide (LSD) and psilocybin shift patient brain dynamics closer to criticality.
Naji L.N. Alnagger +17 more
wiley +1 more source
In Silico Modeling and Characterization of Epstein-Barr Virus Latent Membrane Protein 1 Protein. [PDF]
Salam DDA +5 more
europepmc +1 more source

